• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弗雷明汉风险评分预测心血管疾病:来自南欧的基于人群的研究。

Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe.

机构信息

Community Medicine, Zone 3 Primary Health Care Centre, Albacete, Spain.

出版信息

PLoS One. 2013 Sep 5;8(9):e73529. doi: 10.1371/journal.pone.0073529. eCollection 2013.

DOI:10.1371/journal.pone.0073529
PMID:24039972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3764050/
Abstract

BACKGROUND

The question about what risk function should be used in primary prevention remains unanswered. The Framingham Study proposed a new algorithm based on three key ideas: use of the four risk factors with the most weight (cholesterol, blood pressure, diabetes and smoking), prediction of overall cardiovascular diseases and incorporating the concept of vascular age. The objective of this study was to apply this new function in a cohort of the general non Anglo-Saxon population, with a 10-year follow-up to determine its validity.

METHODS

The cohort was studied in 1992-94 and again in 2004-06. The sample comprised 959 randomly-selected persons, aged 30-74 years, who were representative of the population of Albacete, Spain. At the first examination cycle, needed data for the new function were collected and at the second examination, data on all events were recorded during the follow-up period. Discrimination was studied with ROC curves. Comparisons of prediction models and reality in tertiles (Hosmer-Lemeshow) were performed, and the individual survival functions were calculated.

RESULTS

The mean risks for women and men, respectively, were 11.3% and 19.7% and the areas under the ROC curve were 0.789 (95%CI, 0.716-0.863) and 0.780 (95%CI, 0.713-0.847) (P<0.001, both). Cardiovascular disease events occurred in the top risk tertiles. Of note were the negative predictive values in both sexes, and a good specificity in women (85.6%) and sensitivity in men (79.1%) when their risk for cardiovascular disease was high. This model overestimates the risk in older women and in middle-aged men. The cumulative probability of individual survival by tertiles was significant in both sexes (P<0.001).

CONCLUSIONS

The results support the proposal for "reclassification" of Framingham. This study, with a few exceptions, passed the test of discrimination and calibration in a random sample of the general population from southern Europe.

摘要

背景

在初级预防中应该使用哪种风险函数的问题仍然没有答案。弗雷明汉研究提出了一种新的算法,基于三个关键理念:使用权重最大的四个风险因素(胆固醇、血压、糖尿病和吸烟)、预测整体心血管疾病和纳入血管年龄的概念。本研究的目的是在一个非盎格鲁-撒克逊人群的队列中应用这种新功能,并进行 10 年的随访,以确定其有效性。

方法

该队列于 1992-94 年和 2004-06 年进行了研究。样本包括 959 名随机选择的年龄在 30-74 岁之间的代表性人群。在第一个检查周期中,收集了新功能所需的数据,在第二个检查周期中,记录了随访期间的所有事件数据。使用 ROC 曲线研究了区分度。进行了预测模型与现实的三分位数(Hosmer-Lemeshow)比较,并计算了个体生存函数。

结果

女性和男性的平均风险分别为 11.3%和 19.7%,ROC 曲线下面积分别为 0.789(95%CI,0.716-0.863)和 0.780(95%CI,0.713-0.847)(P<0.001,均)。心血管疾病事件发生在风险最高的三分位数。值得注意的是,在两性中,阴性预测值均为阳性,并且在女性(85.6%)和男性(79.1%)心血管疾病风险较高时,特异性较好,敏感性较高。该模型高估了老年女性和中年男性的风险。两性的个体生存累积概率按三分位数显著(P<0.001)。

结论

结果支持“重新分类”弗雷明汉的建议。除了一些例外,本研究通过了对来自南欧的一般人群的随机样本的区分和校准测试。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c08e/3764050/eaedee9d08bb/pone.0073529.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c08e/3764050/8e2bb13d4ec1/pone.0073529.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c08e/3764050/aa7a2dd0fed8/pone.0073529.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c08e/3764050/5c892c6a2455/pone.0073529.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c08e/3764050/eaedee9d08bb/pone.0073529.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c08e/3764050/8e2bb13d4ec1/pone.0073529.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c08e/3764050/aa7a2dd0fed8/pone.0073529.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c08e/3764050/5c892c6a2455/pone.0073529.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c08e/3764050/eaedee9d08bb/pone.0073529.g004.jpg

相似文献

1
Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe.弗雷明汉风险评分预测心血管疾病:来自南欧的基于人群的研究。
PLoS One. 2013 Sep 5;8(9):e73529. doi: 10.1371/journal.pone.0073529. eCollection 2013.
2
Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study.利用弗雷明汉和SCORE风险模型对女性心血管疾病死亡率进行独立外部验证:一项死亡率随访研究。
BMC Womens Health. 2014 Sep 26;14:118. doi: 10.1186/1472-6874-14-118.
3
Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.代谢综合征人群的心血管风险预测:弗明汉算法与英国前瞻性糖尿病研究(UKPDS)算法
Eur J Prev Cardiol. 2014 Mar;21(3):384-90. doi: 10.1177/2047487312449307. Epub 2012 May 15.
4
Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study.弗雷明汉一般心血管疾病风险评分在多民族亚洲人群中的验证:一项回顾性队列研究。
BMJ Open. 2015 May 19;5(5):e007324. doi: 10.1136/bmjopen-2014-007324.
5
Validity Assessment of Low-risk SCORE Function and SCORE Function Calibrated to the Spanish Population in the FRESCO Cohorts.FRESCO队列中低风险SCORE函数及针对西班牙人群校准的SCORE函数的有效性评估
Rev Esp Cardiol (Engl Ed). 2018 Apr;71(4):274-282. doi: 10.1016/j.rec.2017.03.030. Epub 2017 May 26.
6
Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.新西兰不同种族的弗雷明汉心血管风险评分表现:PREDICT CVD - 10。
N Z Med J. 2010 Feb 19;123(1309):50-61.
7
[Validation and generalizability of the predictive model of ischemic cardiovascular diseases in Chinese].[中国缺血性心血管疾病预测模型的验证与推广]
Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Aug;35(8):761-4.
8
[Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study].[REGICOR研究人群队列中10年心血管疾病风险评估的相对有效性]
Rev Esp Cardiol. 2011 May;64(5):385-94. doi: 10.1016/j.recesp.2010.12.011. Epub 2011 Apr 8.
9
Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study.哥本哈根市心脏研究与弗雷明汉心脏研究中中风概率的比较。
Stroke. 1994 Apr;25(4):802-7. doi: 10.1161/01.str.25.4.802.
10

引用本文的文献

1
Cardiovascular Risk among People Living with HIV in Ghana.加纳艾滋病毒感染者的心血管风险
Infect Chemother. 2025 Jun;57(2):238-247. doi: 10.3947/ic.2024.0138. Epub 2025 Apr 14.
2
Evaluating Treatment Prioritization Rules via Rank-Weighted Average Treatment Effects.通过秩加权平均治疗效果评估治疗优先级规则
J Am Stat Assoc. 2025;120(549):38-51. doi: 10.1080/01621459.2024.2393466. Epub 2024 Oct 11.
3
Assessing the association between dairy consumption and the 10-year Framingham Risk Score in women.评估女性乳制品摄入量与10年弗明汉风险评分之间的关联。

本文引用的文献

1
Framingham risk score and alternatives for prediction of coronary heart disease in older adults.弗雷明汉风险评分及其他方法在预测老年人冠心病中的应用。
PLoS One. 2012;7(3):e34287. doi: 10.1371/journal.pone.0034287. Epub 2012 Mar 28.
2
Systematic examination of the updated Framingham heart study general cardiovascular risk profile.对更新后的弗雷明汉心脏研究一般心血管风险概况的系统检查。
Circulation. 2009 Aug 4;120(5):384-90. doi: 10.1161/CIRCULATIONAHA.108.835470. Epub 2009 Jul 20.
3
An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
BMC Nutr. 2025 Apr 11;11(1):73. doi: 10.1186/s40795-025-01050-0.
4
Framingham score adapted: a valid alternative for estimating cardiovascular risk in epidemiological studies.改良的弗明汉评分:流行病学研究中评估心血管风险的有效替代方法。
BMC Cardiovasc Disord. 2025 Mar 15;25(1):187. doi: 10.1186/s12872-025-04579-x.
5
A new understanding of coronary curvature and haemodynamic impact on the course of plaque onset and progression.对冠状动脉曲率及其对斑块发生和进展过程血流动力学影响的新认识。
R Soc Open Sci. 2024 Sep 11;11(9):241267. doi: 10.1098/rsos.241267. eCollection 2024 Sep.
6
Association between health literacy and Framingham risk score.健康素养与弗雷明汉风险评分的关系。
Sci Rep. 2024 Jun 4;14(1):12837. doi: 10.1038/s41598-024-63607-6.
7
Sex differences in the applicability of Western cardiovascular disease risk prediction equations in the Asian population.亚洲人群中西方心血管疾病风险预测方程在适用性方面的性别差异。
PLoS One. 2024 Jan 31;19(1):e0292067. doi: 10.1371/journal.pone.0292067. eCollection 2024.
8
Occupational Physical Activity and Cardiometabolic Risk Factors: A Cross-Sectional Study.职业体力活动与心血管代谢危险因素:一项横断面研究。
Nutrients. 2023 Mar 15;15(6):1421. doi: 10.3390/nu15061421.
9
Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypes.极端表型定义的代谢综合征的转录组学、表观遗传学和代谢特征。
Clin Epigenetics. 2022 Mar 12;14(1):39. doi: 10.1186/s13148-022-01257-z.
10
Triglyceride Glucose Index Is Associated With Arterial Stiffness and 10-Year Cardiovascular Disease Risk in a Chinese Population.甘油三酯葡萄糖指数与中国人群的动脉僵硬度及10年心血管疾病风险相关。
Front Cardiovasc Med. 2021 Mar 19;8:585776. doi: 10.3389/fcvm.2021.585776. eCollection 2021.
QRISK心血管疾病风险预测的独立外部验证与评估:一项前瞻性开放队列研究。
BMJ. 2009 Jul 7;339:b2584. doi: 10.1136/bmj.b2584.
4
Predicting the 30-year risk of cardiovascular disease: the framingham heart study.预测心血管疾病的30年风险:弗雷明汉心脏研究
Circulation. 2009 Jun 23;119(24):3078-84. doi: 10.1161/CIRCULATIONAHA.108.816694. Epub 2009 Jun 8.
5
Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis.短期风险低但终生心血管疾病估计风险高的年轻成年人中亚临床动脉粥样硬化的患病率和进展:青年动脉粥样硬化风险发展研究和动脉粥样硬化多民族研究
Circulation. 2009 Jan 27;119(3):382-9. doi: 10.1161/CIRCULATIONAHA.108.800235. Epub 2009 Jan 12.
6
[Cardiovascular risk factors. Insights from Framingham Heart Study].[心血管危险因素。弗雷明汉心脏研究的见解]
Rev Esp Cardiol. 2008 Mar;61(3):299-310.
7
General cardiovascular risk profile for use in primary care: the Framingham Heart Study.用于初级保健的一般心血管风险概况:弗雷明汉心脏研究
Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.
8
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.英国一种新型心血管疾病风险评分QRISK的推导与验证:前瞻性开放队列研究
BMJ. 2007 Jul 21;335(7611):136. doi: 10.1136/bmj.39261.471806.55. Epub 2007 Jul 5.
9
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2007年动脉高血压管理指南:欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理特别工作组制定
J Hypertens. 2007 Jun;25(6):1105-87. doi: 10.1097/HJH.0b013e3281fc975a.
10
Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.弗雷明汉心血管风险函数改编版的有效性:VERIFICA研究。
J Epidemiol Community Health. 2007 Jan;61(1):40-7. doi: 10.1136/jech.2005.038505.